Literature DB >> 2722383

Gallstone growth, size, and risk of gallbladder cancer: an interracial study.

A B Lowenfels1, A M Walker, D P Althaus, G Townsend, L Domellöf.   

Abstract

To investigate gallstone size, growth, and the relation between stone size and gallbladder cancer we have used cholecystectomy reports from 1676 female subjects (169 Whites, 531 Blacks, and 976 Native American Indians). Although the prevalence of gallstones differs markedly in these groups it appears that the estimated growth rate of gallstones in younger subjects, 2.0 mm per year (95% confidence interval: 1.7-2.3 mm) is homogeneous for all three groups. In both Indian and non-Indian populations the proportion of small stones diminished and the proportion of large stones increased over time. We found a strong relationship between gallstone size and gallbladder cancer. Large stones (greater than or equal to 3 cm) were found in 40% of patients with gallbladder cancer but in only 12% of all subjects of similar age. The relative risk for gallbladder cancer in subjects with stones greater than or equal to 3 cm was 9.2 compared with subjects with stones less than 1 cm. (95% confidence interval: 2.3-37). We estimate that one-third of all gallbladder cancers in subjects with calculi will be associated with large (greater than or equal to 3 cm) stones. We believe that stone size might be used to determine the risk of gallbladder cancer in patients with gallstones.

Entities:  

Mesh:

Year:  1989        PMID: 2722383     DOI: 10.1093/ije/18.1.50

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  38 in total

1.  Number and size of stones in patients with asymptomatic and symptomatic gallstones and gallbladder carcinoma.

Authors:  Iván Serra; Andrew K Diehl
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

2.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

3.  Fatal abdominal hemorrhage associated with gallbladder perforation due to large gallstones.

Authors:  Luis R Soto; Harold R Levine; Scott A Celinski; Joseph M Guileyardo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-04

Review 4.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

Review 5.  The Landmark Series: Gallbladder Cancer.

Authors:  Adriana C Gamboa; Shishir K Maithel
Journal:  Ann Surg Oncol       Date:  2020-05-30       Impact factor: 5.344

6.  Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.

Authors:  Chiara Gabbi; Hyun-Jin Kim; Rodrigo Barros; Marion Korach-Andrè; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

7.  Analysis of mortality rates for gallbladder cancer across the world.

Authors:  D Hariharan; A Saied; H M Kocher
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

8.  Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study.

Authors:  Hsueh-Chou Lai; Shih-Ni Chang; Che-Chen Lin; Ching-Chou Chen; Jen-Wei Chou; Cheng-Yuan Peng; Shih-Wei Lai; Fung-Chang Sung; Yu-Fen Li
Journal:  J Gastroenterol       Date:  2012-10-16       Impact factor: 7.527

9.  Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China.

Authors:  G Andreotti; L Hou; Y-T Gao; L A Brinton; A Rashid; J Chen; M-C Shen; B-S Wang; T-Q Han; B-H Zhang; L C Sakoda; J F Fraumeni; A W Hsing
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

10.  Twenty years after Erich Muhe: Persisting controversies with the gold standard of laparoscopic cholecystectomy.

Authors:  Kalpesh Jani; P S Rajan; K Sendhilkumar; C Palanivelu
Journal:  J Minim Access Surg       Date:  2006-06       Impact factor: 1.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.